LMP-2:340-349 Peptide Vaccine

A peptide vaccine containing amino acids residues from 340 through 349 of the latent membrane protein-2 (LMP-2) of the Epstein-Barr virus (EBV) with potential immunostimulating and antineoplastic activities. LMP-2, an EBV transmembrane protein, is expressed in various malignancies including nasopharyngeal cancer and EBV-positive Hodgkin's disease. Vaccination with the LMP-2:340-349 peptide may boost the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against LMP-2 producing cells, resulting in cell lysis and inhibition of cancer cell proliferation. (NCI Thesaurus)

YOU MAY ALSO LIKE

LMO2 wt Allele

Human LMO2 wild-type allele is located in the vicinity of 11p13 and is approximately 34 kb in length. This allele, which encodes…

LMO2 Gene

This gene plays a crucial role in hematopoietic development and is involved in transcriptional activation.

LMO1 wt Allele

Human LMO1 wild-type allele is located in the vicinity of 11p15 and is approximately 44 kb in length. This allele, which encodes…

LMO1 Gene

This gene is involved in the regulation of transcription.

LMNB1 wt Allele

Human LMNB1 wild-type allele is located within 5q23.3-q31.1 and is approximately 60 kb in length. This allele, which encodes lamin-B1 protein, is…

LMNB1 Gene

This gene is involved in mitosis and apoptosis.